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Standard Imaging – 13 chambers, Nucletron Holland – 9 
chambers, and PTW Freiberg – 8 chambers. 
 
Results: Mean values and SD of calibration coefficients for 
each chamber type were calculated. For Standard Imaging 
HDR1000 Plus well chambers the mean calibration coefficient 
was 0.4669±0.0026. For Nucletron Holland well chambers 
(type 77091, 77092 and 77094) the mean calibration 
coefficient was 0.9472±0.0142 and for PTW33004 well 
chambers the mean calibration coefficient was 
0.9655±0.0186. Some chambers were calibrated twice, what 
allowed for evaluation of their stability. 
 
Conclusion: The smallest standard deviation of the 
calibration factors was observed for the Standard Imaging 
chambers (13 chambers). It indicates high manufacturing 
reproducibility. Furthermore, these chambers have higher 
sensitivity than the other types. Two chambers of each type 
were calibrated twice over a period of two years. Their long-
term stability is comparable, and is within 0.5% per two years 
for all types. The secondary standard of the SSDL, a PTW well 
chamber type TW33004, was calibrated at the PTW 
laboratory and also at the Primary Standard Laboratory PTB-
Braunschweig, Germany. The calibration factors from both 
labs differed by 1%. The SSDL relies on the Primary Standard 
calibration. The data for PTW chambers, calibrated at the 
manufacturer and at the Polish SSDL indicate slight deviations 
of the PTW calibration factors in one direction. This might 
suggest the systematic difference in the calibration 
procedure between the PTW and PTB. 
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Purpose or Objective: Experimental and theoretical 
dosimetry of the RIC-100 P-32 brachytherapy source is 
presented for implant geometries that may occur in an 
intraoperative setting during treatment of localized spinal 
tumors with temporary superficial radiation. Dose variation, 
due to source shape and size, is evaluated, and non-ideal 
implant conditions are simulated. Superficial brachytherapy 
has been used to prevent local recurrence and minimize 
neurological toxicity after surgical resection of paraspinous 
tumors abutting the dura. In this procedure, a brachytherapy 
source with limited penetration is applied directly to the 
tumor site in an intraoperative setting, thus providing a 
technique for localized treatment delivery that maximizes 
normal tissue sparing. 
 
Material and Methods: Calibration, depth dose, and dose 
profiles were evaluated for several implant geometries and 
source sizes. Experimental measurements were performed 
using EBT3 gafchromic film. Theoretical calculations were 
performed using dose point kernel (DPK) formalism, which 
simulates isotropic, monoenergetic point sources distributed 
uniformly throughout the source and emitting electrons 
radially outwards. 
 
Results: Calibration and depth-dose for RIC-100 are 
independent of source size for diameters >1cm. Sources 
should be ordered with physical dimensions ~0.2 cm larger 
than the target size, in all dimensions, to deliver >90% 
prescription dose to target edges. Relative dose profile shape 
is approximately constant as a function of target depth. Air-
gaps between the source and target cause narrower dose 
profile widths and shallower depth-dose in the therapeutic 
range. The figure shown below presents the dosimetric 
effects of an air gap between the source and target. 
Measured dose profiles (solid lines) are shown for a water 
equivalent depth equal to 0.153 cm and air gaps of 0, 0.14, 
and 0.44 cm separating the source surface from the phantom. 
Theoretical dosimetry is provided for comparison (dashed 
lines). 
 
 
Finally, DPK for RIC-100 agrees with published P-32 kernels, 
and DPK calculations agree with measurement (within 5%) for 
many depths and geometries. 
 
Conclusion: Intraoperative placement and measurement 
dosimetry of RIC-100 require careful setup due to steep dose 
gradients. Physical source dimensions should be chosen 
carefully based on treatment site dimensions, and air-gaps 
between source and target should be minimized, to prevent 
under-dosing the target in the lateral extent. Radiological 
scaling should be used to calculate expected dose when non-
water materials are used in experimental measurements, 
such as calibration or depth dose. 
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Purpose or Objective: Multichannel Vaginal Cylinders (MVCs) 
allow to perform conformal HDR brachytherapy (BT) 
treatments for vaginal vault cancers. Despite the fact that 
with MVCs the degrees of freedom for treatment planning 
have significantly increased with respect to common vaginal 
cylinders, no unique indications are currently given on how to 
perform dose distribution optimization. Purpose of this study 
was to compare several optimization methods (OM) 
implemented in Oncentra Brachy (Nucletron Elekta), with a 
particular attention to the target coverage and the 
simultaneous limitation of hot spots to the vaginal mucosa 
and the improvement of dose homogeneity to the target. 
 
Material and Methods: The study was based on 12 vaginal 
cancer cases treated with HDR BT (25Gy/5 fractions) as boost 
after external beam radiotherapy (45Gy/25 fractions). MVC 
applicators with diameters of 25mm (6 cases) and 30mm (6 
cases) were used and treatments were retrospectively 
planned using four OM: i) a combination of geometrical and 
graphical OM (GrO); ii) the Inverse Planning by Simulated 
Annealing (IPSA) method, imposing surface dose constraints 
on the PTV (surfIPSA); iii) the IPSA method, applying further 
dose constraints to the applicator surface (homogIPSA); iv) 
the Hybrid Inverse Planning Optimization (HIPO) with 
previously defined iterative optimization steps. All methods 
had to respect constraints on bladder and rectum 
(respectively D2cc<80% and D2cc<75% of the prescribed 
dose), and to possibly deliver at least a V90>95% to the PTV. 
Plans evaluation was performed in terms of PTV coverage 
(D90, V90), conformity index (COIN), dose homogeneity index 
(DHI) and ratio between source dwelling times in the central 
and peripheral catheters (%CC). As maximum dose to the 
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vaginal mucosa the D0.1cc was considered. Statistical 
significance of the results was proven by a Wilcoxon test for 
paired samples (significant p-value <0.05) 
 
Results: 
 
 
Table 1 shows the obtained values for D90, V90, COIN, DHI 
and %CC for the investigated OM. No significant differences 
resulted among the OM in terms of target coverage (D90 and 
V90) and bladder and rectum sparing (D2cc).  
 
The figure shows average DVHs of the PTV over all 12 cases. 
DVHs obtained with homogIPSA and HIPO show a steeper 
gradient, resulting in smaller volumes exposed to high doses. 
homogIPSA and HIPO result in significantly better values of 
COIN, DHI e %CC values. Furthermore, homogIPSA shows the 
lowest value for the D0.1cc to the mucosa. No differences 
were evidenced between the use of MVC applicators with 
diameters of 25mm and 30mm. 
 
Conclusion: HIPO and homogIPSA should be preferred due to 
their ability to get improved dose homogeneity to the target 
and reduced hot spots to the vaginal mucosa. This is achieved 
by a more effective distribution of source dwelling times 
between central and peripheral catheters. It has to be noted 
that all investigated OM require experience of the planner 
and are not completely user independent. 
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Purpose or Objective: To investigate the dosimetric 
characteristics of GMS BT-125-1 I-125 radioactive seed, 
including dose rate constant, radial dose functions and 
anisotropy functions. 
 
Material and Methods: Dosimetric parameters of GMS BT-
125-1 I-125 seed, including dose rate constant, radial dose 
functions and anisotropy functions were calculated using the 
Monte Carlo code of MCNP5, and measured using 
thermoluminescent dosimeters (TLDs). Monte Carlo 
calculations were also performed for the PharmaSeed BT-125-
1 I-125 seed, PharmaSeed BT-125-2 I-125 seed and model 
6711 I-125 seed. The dosimetric parameters of GMS BT-125-1 
I-125 seed were compared with those of PharmaSeed BT-125-
1 I-125 seed, PharmaSeed BT-125-2 I-125 seed and model 
6711 I-125 seed. The measured results were compared with 
those of Monte Carlo simulation for GMS BT-125-1 I-125 seed. 
 
Results: The MCNP5 calculated dose rate constant of GMS BT-
125-1 I-125 seed was 1.011 . The experimental measured 
dose rate constant of GMS BT-125-1 I-125 seed was 0.967 . 
For radial dose function, the difference between GMS BT-
125-1 I-125 seed and PharmaSeed BT-125-2 I-125 seed were 
typically less than 2.0% with a maximum of 3.3 %. The largest 
differences were 8.1% and 6.2% compared with PharmaSeed 
BT-125-1 and model 6711 I-125 seed, respectively. For 
anisotropy functions, the difference between GMS BT-125-1 I-
125 seed and PharmaSeed BT-125-2 I-125 seed was typically 
<10% with a maximum of about 9.6% when the polar angle 
was larger than 10 degree, and 22.9% when the polar angle 
was smaller than 10 degree. Compared with Monte Carlo 
simulation, the largest differences of radial dose functions 
and anisotropy functions were 14.5% and 29.1%, respectively.  
 
Conclusion: The measured dose rate constant, radial dose 
functions and anisotropy functions for GMS BT-125-1 I-125 
seed showed good agreement with Monte Carlo calculated 
values. The dosimetric parameters of GMS BT-125-1 I-125 
seed are similar to those of PharmaSeed BT-125-2 I-125 seed.  
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Purpose or Objective: The aim of this study was: (i) to 
design a new high-dose-rate (HDR) brachytherapy applicator 
for treating surface lesions larger than 3 cm in diameter and 
up to 5 cm size, using the microSelectron-HDR afterloader 
(Elekta Brachytherapy); (ii) to calculate by means of the 
Monte Carlo (MC) method the dose distribution around the 
new applicator when it is placed over a water phantom; and 
(iii) to validate experimentally the water dose distributions. 
 
Material and Methods: The new applicator is made of 
tungsten, and consists on a set of interchangeable collimators 
without flattening filter. It makes use of three catheters to 
allocate the source at prefixed dwell positions and times to 
produce a homogeneous dose distribution at 3 mm depth in 
the water phantom. The Penelope2008 MC code was used to 
optimize dwell positions and dwell times. Next, the dose 
distribution in a water phantom and leakage dose distribution 
were calculated. Finally, MC data were validated 
experimentally by measuring: dose distributions with 
radiochromic EBT3 films (ISP) for an 192Ir mHDR-v2 source; 
percentage depth-dose (PDD) curve with the parallel-plate 
ionization chamber Advanced Markus (PTW); and absolute 
dose rate with EBT3 films and the PinPoint T31016 (PTW) 
ionization chamber. 
 
Results: PDD and off-axis profiles were obtained normalized 
at a depth of 3 mm along the central applicator axis in a 
cylindrical water phantom. These data can be used for 
treatment planning. Leakage was also scored. The dose 
distributions, PDD, and absolute dose rate calculated agree 
within experimental uncertainties with the doses measured. 
 
Conclusion: The new applicator and the dosimetric data 
provided here will be a valuable tool in clinical practice, 
making treatment of large skin lesions simpler, faster, safer, 
and with minimized dose to surrounding healthy tissues when 
